H2 blockers in the prevention of paclitaxel-related hypersensitivity reaction
Natl Med J India
.
2021 Nov-Dec;34(6):350-351.
doi: 10.25259/NMJI_489_21.
Authors
Vinod Sharma
1
,
Akash Kumar
1
Affiliation
1
Department of Medical Oncology National Cancer Institute All India Institute of Medical Sciences Jhajjar, Haryana, India.
PMID:
35818100
DOI:
10.25259/NMJI_489_21
No abstract available
Publication types
Comment
MeSH terms
Drug Hypersensitivity* / etiology
Drug Hypersensitivity* / prevention & control
Histamine H2 Antagonists
Humans
Paclitaxel* / adverse effects
Substances
Histamine H2 Antagonists
Paclitaxel